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Major traumatic injury induces significant remodeling of the circulating neutrophil pool
and loss of bactericidal function. Although a well-described phenomenon, research
to date has only analyzed blood samples acquired post-hospital admission, and the
mechanisms that initiate compromised neutrophil function post-injury are therefore poorly
understood. Here, we analyzed pre-hospital blood samples acquired from 62 adult
trauma patients (mean age 44 years, range 19–95 years) within 1 h of injury (mean time
to sample 39min, range 13–59min). We found an immediate impairment in neutrophil
extracellular trap (NET) generation in response to phorbol 12-myristate 13-acetate
(PMA) stimulation, which persisted into the acute post-injury phase (4–72 h). Reduced
NET generation was accompanied by reduced reactive oxygen species production,
impaired activation of mitogen-activated protein kinases, and a reduction in neutrophil
glucose uptake and metabolism to lactate. Pre-treating neutrophils from healthy subjects
with mitochondrial-derived damage-associated molecular patterns (mtDAMPs), whose
circulating levels were significantly increased in our trauma patients, reduced NET
generation. This mtDAMP-induced impairment in NET formation was associated with
an N-formyl peptide mediated activation of AMP-activated protein kinase (AMPK), a
negative regulator of aerobic glycolysis and NET formation. Indeed, activation of AMPK
via treatment with the AMP-mimetic AICAR significantly reduced neutrophil lactate
production in response to PMA stimulation, a phenomenon that we also observed for
neutrophils pre-treated with mtDAMPs. Furthermore, the impairment in NET generation
induced by mtDAMPs was partially ameliorated by pre-treating neutrophils with the
AMPK inhibitor compound C. Taken together, our data demonstrate an immediate
trauma-induced impairment in neutrophil anti-microbial function and identify mtDAMP
release as a potential initiator of acute post-injury neutrophil dysfunction.
Keywords: neutrophils, neutrophil extracellular traps, trauma, mitochondrial-derived DAMPs, immune
suppression
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INTRODUCTION
Major injury induces significant phenotypic and functional
remodeling of the peripheral neutrophil pool, attributable in part
to the emergence into circulation of immature granulocytes (IGs)
and highly mature neutrophil subsets (1–5). Alongside changes
in the surface expression of adhesion molecules and chemokine
receptors (6–8), immediate and prolonged impairments in
phagocytosis (1, 9), reactive oxygen species (ROS) production
(1, 3), and chemotaxis (10, 11) have been reported for neutrophils
isolated from critically-injured patients. Whilst understanding of
trauma-induced changes in neutrophil intracellular bactericidal
function is well-developed, few studies have investigated the
impact of injury on the extracellular defensive mechanisms of
neutrophils and how soon after injury, any compromise occurs.
Comprised of a DNA backbone decorated with granular and
cytosol-derived peptides and enzymes, neutrophil extracellular
traps (NETs) are an extracellular anti-microbial defense
mechanism deployed to prevent pathogen dissemination (12).
Studies that have examined NET generation post-injury have
reported an increase in ex vivo NET formation by resting
neutrophils (10, 13), a hyperactivity that may reflect their
in vivo exposure to high mobility group box-1 (HMGB-1)
and interleukin (IL)-33, two NET-inducing alarmins whose
circulating concentrations are significantly increased post-injury
(14–16). However, in terms of stimulus-induced NET generation,
comparable (13), or reduced (1, 10) NET production in response
to stimulation with phorbol 12-myristate 13-acetate (PMA)
has been reported post- trauma. Of these studies, only one
performed quantitative analysis (1), and neither study that
reported a post-injury reduction in NET formation investigated
the mechanism(s) responsible (1, 10).
Activation of three non-redundant molecular processes
underpin PMA-induced NET generation. Produced by the multi-
subunit enzyme nicotinamide adenine dinucleotide phosphate
(NADPH) oxidase, ROS generation is essential for the process
of chromatin decondensation that precedes NET release (17,
18). Occuring prior to (19) or following (20) ROS production,
activation of the mitogen activated protein kinases p38 and
extracellular signal regulated kinase 1/2 (ERK 1/2), triggers
NET formation by inhibiting caspase activation and increasing
expression of the pro-survival protein Mcl-1, thus promoting
NET production over the induction of apoptosis (19, 20).
Finally, glycolysis is a fundamental metabolic requirement for
PMA-induced NET formation, with the uptake and breakdown
of extracellular glucose a necessity for the process of DNA
expulsion (21).
Trauma-associated tissue damage results in the release
into the circulation of damage-associated molecular patterns
(DAMPs), a collection of cytosolic, mitochondrial and nuclear-
derived proteins, and DNA (14, 22, 23). Whilst renowned for
their role in immune activation (23, 24), data are emerging
that suggests mitochondrial-derived DAMPs (mtDAMPs),
which include N-formylated peptides and mitochondrial DNA
(mtDNA), possess immune tolerising properties. For instance,
it has been shown in vitro that monocytes pre-exposed to
mtDNA (25) and neutrophils pre-treated with whole mtDAMP
preparations (23) exhibit impaired cytokine production and
calcium mobilization respectively upon secondary stimulation.
Furthermore, a significant reduction in stimulus-induced ROS
production and transmigration was reported for neutrophils
pre-exposed to bacterial-derived or synthetic N-formylated
peptides (10, 22, 26), both of which signal through the same
formyl peptide receptor (FPR) as mitochondrial-derived
formyl peptides. Based on these observations, the concept of
mtDAMP-induced tolerance has been coined and proposed to
be a potential mechanistic explanation for the state of peripheral
neutrophil dysfunction that develops in the aftermath of major
trauma (10, 22).
Here, in a prospective observational study of trauma
patients, we have performed for the first time a quantitative
assessment of NET production during the pre-hospital, ultra-
early (≤60min), and acute (4–72 h) post-injury phases, and
assessed the impact that major injury has on the molecular
processes and signaling pathways that underpin PMA-induced
NET generation. Furthermore, based on the emerging concept of
mtDAMP-induced tolerance, we have investigated whether pre-
exposing neutrophils isolated from healthy subjects to mtDAMPs
in vitro results in altered NET generation upon secondary
stimulation with PMA and the mechanisms involved.
MATERIALS AND METHODS
Study Design and Setting
This manuscript presents data acquired from subjects enrolled
into the Brain Biomarkers after Trauma Study, an ongoing
prospective longitudinal observational study of adult trauma
patients conducted at a single Major Trauma Center site in the
UK (University Hospitals Birmingham NHS Foundation Trust,
Birmingham). Ethical approval for the study was granted by the
North Wales Research Ethics Committee–West (REC reference:
13/WA/0399, Protocol Number: RG_13-164).
Patient enrolment began in the pre-hospital setting, where on
a 24/7 basis between March 2016 and October 2018, emergency
care teams acquired blood samples from adult trauma patients
(≥18 years) with a suspected injury severity score (ISS) ≥8
within 1 h of injury (defined as the time of phone call to
emergency services). In the pre-hospital setting, blood samples
were not taken from patients who were deemed unlikely to
survive transportation to hospital. Post admission, patients were
excluded if they were aged <18 years, if pre-hospital blood
samples had been acquired >1 h post-injury and if clinical
assessments confirmed either an ISS<8 or a previous diagnosis of
neuro-degenerative disease. No patients received blood products
in the pre-hospital setting.
Capacity and Consent
Due to the nature of injuries sustained, patients were unlikely
to provide informed consent for their participation at the time
of study enrolment. Consequently, patient recruitment was
performed under the guidance of theMental Health Capacity Act
2005 for research in emergency situations and the Declaration
of Helsinki. For patients who lacked capacity, an agreement for
study participation was sought from a legal consultee (family
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member or clinician not directly involved in the study), with
written consent obtained from the patient once they regained
capacity. In instances where the patient did not regain capacity,
data were retained in accordance with the agreement of the
legal consultee.
Blood Sampling
In the pre-hospital environment, peripheral venous blood
samples were acquired during the intravenous cannulation of
patients or by venepuncture. Once taken, blood tubes were
stored at room temperature (RT) until arrival at hospital, where
analysis began within 1 h by a single laboratory researcher
on a 24/7 basis. Additional blood samples were acquired 4–
12 and 48–72 h post-injury. At all three time points, blood
samples were collected into BD Vacutainers R© (BD Biosciences,
Oxford, UK) containing ethylenediaminetetraacetic acid, z-
serum clotting activator or 1/10 volume of 3.2% trisodium citrate.
Full blood counts were performed using a Sysmex XN-1000
hematology analyser (Sysmex UK, Milton Keynes, UK) that
measures a white cell differential and IGs, which are defined as
promyelocytes, myelocytes, and metamyelocytes. The analyser
uses fluorescence dyes that label intracellular DNA and RNA,
with the intensity of the fluorescence signal directly proportional
to the nucleic acid content of the cell. Due to their higher
RNA content, IGs are discriminated frommature neutrophils via
their stronger fluorescence signal. Daily internal quality control
measurements (XN check, Sysmex UK) and monthly external
quality control samples (UKNEQAS, Watford, UK) ensured
instrument performance.
Sixty-seven adults (mean age 31 years, range 18–80) served
as a cohort of healthy controls (HCs). HCs were volunteers who
were not taking any regular medication for a diagnosed illness
and did not have an acute episode of infection prior to the
time of sampling. The recruitment of HCs was carried out in
accordance with the ethical approval granted by the University
of Birmingham Research Ethics Committee (Ref: ERN_12-1184)
with written informed consent from all subjects. All subjects gave
written informed consent in accordance with the Declaration
of Helsinki.
Preparation of mtDAMPs and mtDNA
MtDNA and mtDAMPs were prepared from mitochondria
isolated from the K562 tumor cell line (ATCC R©, Teddington,
Middlesex, UK) as described previously (24). MtDNA
concentration and protein content within mtDAMPs were
determined by spectrophotometry (Nanodrop 2000; Thermo
Fisher Scientific, Paisley, UK) and preparations stored at −80◦C
prior to use.
Neutrophil Isolation and Treatment
Neutrophils were isolated by Percoll density gradient
centrifugation (Scientific Lab Supplies, Nottingham, UK)
with cell purity, which was routinely ≥99%, determined using
a Sysmex XN-1000 hematology analyser. Neutrophils were
re-suspended at concentrations of 1-10 × 106/ml in phenol red
free or phenol red containing RPMI-1640 media supplemented
with 2mM L-glutamine, 100 U/ml penicillin and 100µg/ml
streptomycin (GPS; Sigma-Aldrich, Dorset, UK), phenol red
free or phenol red containing RPMI-1640 media supplemented
with GPS and 10% heat-inactivated fetal calf serum [HI-FCS;
hereafter referred to as complete medium (CM); Sigma-Aldrich],
glucose free RPMI-1640 media supplemented with GPS (Gibco,
Fisher Scientific UK Ltd, Loughborough, UK), Hank’s balanced
salt solution (HBSS) supplemented with calcium and magnesium
(hereafter referred to as HBSS+/+; Gibco, Life Technologies,
Cheshire, UK) or HEPES buffer containing 1 mM Ca2+.
For mtDAMPs and mtDNA experiments, neutrophils were
pre-treated for 15min (37◦C/5% CO2) with 40 or 100µg/ml
mtDAMPs or mtDNA prior to secondary stimulation. Prior to
inclusion in transmigration, lactate and ROS assays, neutrophils
were pelleted, supernatants removed, and cells resuspended in
specified media. To inhibit FPR-1 signaling, neutrophils were
treated for 60min (37◦C/5% CO2) with 2.5µM cyclosporin
H (CsH; Abcam, Cambridge, UK) or vehicle control, prior
to mtDAMP stimulation. For compound C experiments,
neutrophils were treated for 60min with 200µM compound C
(Sigma-Aldrich) or vehicle control prior to mtDAMP and PMA
treatment. To inhibit calcium-calmodulin-dependent protein
kinase kinases (CaMKKs), neutrophils were incubated for 60min
(37◦C/5% CO2) with 2.5µM STO-609 (Sigma-Aldrich) or
vehicle control prior to mtDAMP treatment. To induce AMP-
activated protein kinase (AMPK) signaling, neutrophils were
treated for 60min with 1mM AICAR (Sigma-Aldrich) prior to
PMA stimulation.
Ex vivo NET Formation
Neutrophils (2× 105 in phenol red free or phenol red containing
RPMI + GPS or glucose free RPMI-1640 media supplemented
with GPS) were stimulated with 25 nM PMA (Sigma-Aldrich)
for 3 h at 37 ◦C/5% CO2. Post-stimulation, supernatants were
collected and centrifuged at 2,200 x g for 10min at 4◦C, after
which the DNA content of cell-free supernatants was analyzed.
Briefly, 100 µl aliquots of cell-free supernatant were incubated
with 1µM SYTOX Green dye (Life Technologies) for 10min
at RT. Fluorescence was measured using a BioTek Synergy 2
fluorometric plate reader (NorthStar Scientific Ltd, Sandy, UK)
with excitation and emission set at 485 and 528 nm respectively.
In our trauma-based studies, DNA quantification was performed
using a λ-DNA standard curve (Fisher Scientific) with PMA-
induced NET generation presented as DNA concentration after
subtracting the readings obtained from untreated controls. For
mtDAMP experiments, background fluorescence values acquired
from SYTOX Green staining of mtDAMPs in the absence
of neutrophils were subtracted from test readings, with NET
production expressed as a fold increase above untreated controls.
Visualization of NETs by
Fluorescence Microscopy
2 × 105 neutrophils in phenol red free or phenol red containing
RPMI + GPS or glucose free RPMI-1640 media supplemented
with GPS were seeded onto glass coverslips and incubated for
30min at 37◦C/5% CO2 to allow for cell adherence. Following
a 3 h stimulation with 25 nM PMA (37◦C, 5% CO2), samples
were fixed for 30min with 4% paraformaldehyde (37◦C, 5%
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CO2), washed three times in phosphate buffered saline (PBS) and
permeabilised with 0.1% Triton X-100 (Sigma-Aldrich). DNA
was then stained with 1µM SYTOX Green dye for 5min, after
which slides were washed once in PBS, mounted in fluoromount
medium and visualized using a LEICA DMI 6000 B microscope
(LEICA, Milton Keynes, UK) at x20 or x40 objective.
ROS Production
For ex vivo analysis of neutrophils isolated from trauma
patients, ROS generation was assessed by lucigenin-amplified
chemiluminescence. The effect of mtDAMP pre-treatment
on ROS production was examined using luminol-amplified
chemiluminescence. In both instances, 100 µl aliquots of
neutrophils (1 × 106/ml in HBSS+/+) were dispensed into
wells of a 96-well white-bottomed flat plate (BD Biosciences),
pre-coated with PBS/2% BSA, that contained 25 µl of
luminol (pH 7.3; final concentration 100µM; Sigma-Aldrich)
or lucigenin (final concentration 200µM; Sigma-Aldrich) and
50 µl HBSS+/+. Neutrophils were then stimulated with 25 nM
PMA or vehicle control, after which ROS generation was
assessed at 1min intervals for 180min using a Berthold Centro
LB 960 luminometer (Berthold Technologies, Hertfordshire,
UK). Experiments were performed in quadruplicate, with ROS
production measured as relative light units and calculated as area
under the curve (AUC).
Measurement of Lactate Concentration in
Cell-Free Culture Supernatants
Neutrophils (2 × 106 in phenol red free RPMI + GPS)
were stimulated for 1, 2, or 3 h (37◦C, 5% CO2) with
25 nM PMA or vehicle control. At each time-point, cell-
free supernatants were harvested (800 x g, 5min, 4◦C)
and samples stored at −80◦C prior to analysis. Lactate
concentration in 25 µl aliquots of supernatant was determined
using a commercially available lactate assay kit according to
manufacturer’s instructions (Sigma-Aldrich).
Glucose Uptake Assay
Following a 15min rest period at 37◦C/5% CO2, neutrophils (1
× 106 in RPMI-1640 media without glucose) were stimulated for
60min (37◦C/5% CO2) with 25 nM PMA or vehicle. With 10min
of the stimulation period remaining, the fluorescent glucose
analog 2-N-7-nitrobenzen-2oxa-1,3-diazol-4-yl amino-2-
deoxyglucose (2-NBDG; Thermo Fisher) at a final concentration
of 100µM was added. Post-incubation, samples were washed
and cells re-suspended in glucose free RPMI in preparation for
flow cytometric analysis, which was performed on a CyAnTMADP
bench top cytometer (Dako, Cambridgeshire, UK). Ten thousand
neutrophils were collected and FL1 mean fluorescence intensity
values recorded.
Neutrophil Transmigration
Neutrophils (1 × 107/ml) in HEPES buffer containing 1mM
Ca2+ were incubated for 30min in a 37◦C water bath
with 3µg/ml calcein-acetoxmethyl ester (calcein-AM, Fisher
Scientific), after which cells were pelleted, supernatants removed
and neutrophils re-suspended at 1 × 107/ml in phenol red free
CM. A total of 1× 106 neutrophils were dispensed into the upper
chambers of polycarbonate membrane cell culture inserts with
3µMpores (Corning, New York, USA) that had been pre-loaded
into wells of a 24-well flat bottomed plate (BD Biosciences)
containing pre-warmed phenol red free CM and 1 nM LTB4 (R
and D Systems, Abingdon, UK). Following a 90min incubation
at 37◦C, cell culture inserts were removed and plates read
immediately for calcein fluorescence using a BioTek Synergy 2
fluorometric plate reader with excitation and emission set at 485
and 528 nm respectively. Fluorescence intensities were converted
into neutrophil numbers via the use of a standard curve that
was generated from calcein-AM loaded neutrophils that had been
incubated alongside the test samples in the conditions described
above. The number of neutrophils measured in media in which
no chemokine was added was subtracted from the numbers
calculated for wells that contained 1 ng/ml LTB4 in order to
determine specific chemokine-mediated migration.
Assessment of Neutrophil Phenotype
Freshly isolated neutrophils (1 × 105 in CM) were stimulated
with 100µg/ml mtDAMPs or vehicle control for 15min at
37◦C in a humidified 5% CO2 atmosphere. Post–treatment,
samples were stained on ice for 20min with the following mouse
anti-human monoclonal antibodies or their concentration-
matched isotype controls: 2µg/ml fluorescein isothiocyanate
(FITC)-labeled CD62L (clone DREG56; eBioscience, Hatfield,
UK); 1µg/ml CXCR1-FITC (clone eBIO8F1-1-4; eBioscience);
0.5µg/ml R-phycoerythrin (PE)-labeled CXCR2-PE (clone
eBio5E8-C7-F10; eBioscience) or 2.5µg/ml allophycocyanin
(APC)-labeled CD11b (clone ICRF44, BioLegend, London,
UK). Post incubation, cells were pelleted (250 x g, 5min,
4◦C), supernatants discarded and neutrophils washed once
in PBS/1%BSA. Following resuspension in PBS, samples were
transferred to polypropylene FACS tubes for flow cytometric
analysis, which was performed on an AccuriC6TM bench top
cytometer (BD Biosciences). Ten thousand neutrophils, gated
according to their forward scatter (FS)/sideward scatter (SS)
properties, were acquired for analysis, where receptor expression
was measured as median fluorescence intensity (MedFI).
Cell Signaling Measurements
To determine signaling through AMPK and MAPK pathways,
cell lysates prepared from 2 × 106 resting neutrophils, 1 × 106
neutrophils stimulated with either 25 nM PMA or 100µg/ml
mtDAMPs for 2–90min (37◦C/5% CO2), or 2 × 10
6 neutrophils
stimulated with 100µg/ml mtDAMPs for 5min following 1 h
pre-treatment with 2.5µM STO-609 or 2.5µM CsH were
separated on 10 or 12% SDS-polyacrylamide gels. Following
protein transfer to polyvinylidene difluoride membranes (Bio-
Rad, Hertfordshire, UK), blots were probed overnight at 4◦C
with rabbit anti-human antibodies (Cell Signaling Technology,
Massachusetts, USA) directed against phosphorylated AMPK
(pAMPK), phosphorylated ERK1/2 (pERK1/2), phosphorylated
P38 (pP38), lactate dehydrogenase A (LDHA), or pyruvate kinase
(PKM2). Post incubation, membranes were washed in tris-
buffered saline containing 0.001% tween (TBST) and incubated
for 1 h at RT with a goat anti-rabbit secondary antibody
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conjugated to horse radish peroxidase (HRP; diluted 1:4000
in TBST; GE Healthcare, Buckinghamshire, UK). HRP activity
was detected using enhanced chemiluminescence (Bio-Rad).
To confirm equal loading of proteins, blots were probed with
antibodies against total ERK 1/2, total P38 (1:1000; Cell Signaling
Technology), or β-actin (1:5000, GeneTex, California, USA).
Densitometry analysis was performed using Image J software
(National Institutes of Health, Bethesda, MD, USA).
Enzyme-Linked Immunosorbent
Assays (ELISAs)
Serum was prepared from blood collected into BD vacutainers
containing z-serum clotting activator. Following a 30min
incubation at RT, blood samples were centrifuged at 1,620
x g for 10min at 4◦C, after which serum was aliquoted
and stored at −80◦C until analyzed. ELISAs to measure
serum concentrations of HMGB-1 (IBL International, Hamburg,
Germany), mitochondrial encoded NADH dehydrogenase 6
(ND6; MyBioSource, San Diego, California, USA) and IL-
33 (R and D Systems) were performed in accordance with
manufacturer’s instructions.
Statistical Analyses
Statistical analyses were performed using GraphPad Prism R©
software (GraphPad Software Ltd, California, USA). Data
distribution was examined using the Kolmogorov-Smirnov or
Shapiro-Wilk normality test. For data that followed a normal
distribution, paired student t-tests, a repeated measures ANOVA
with Bonferroni multiple comparison post hoc test or a one
way ANOVA with Dunnett’s multiple comparison post hoc test
were performed. For non-normally distributed data, a Wilcoxon
matched-pairs signed rank test, a Friedman test with Dunn’s
multiple comparison post hoc test or a Kruskal-Wallis with
Dunn’s multiple comparison post hoc test was performed. For box
and whisker plots, whiskers represent minimum and maximum
values. Statistical significance was accepted at p ≤ 0.05.
RESULTS
Patient Enrolment and Demographics
1,070 adult trauma patients were screened for study
inclusion, with 87 subjects enrolled into the study
(Supplementary Figure 1). Of these, 62 patients with a mean
age of 44 years (range 19–95 years) and mean injury severity
score of 26 (range 9–57) had their immune function analyzed
(Table 1). The mean time of pre-hospital blood sampling was
39min post-injury (range 13–59 min).
PMA-Induced NET Production Is
Impaired Post-trauma
Compared to neutrophils isolated from HCs, neutrophils
acquired from trauma patients within 1 h of injury exhibited
significantly enhanced basal NET generation (Figure 1A), a
hyperactivity that was accompanied by significantly elevated
serum concentrations of HMGB-1 (Figure 1B) and IL-33
(Figure 1C). By the 4–12 and 48–72 h post-injury time
points, a significant reduction in basal NET production was
TABLE 1 | Cohort demographics.
Patients
(n = 62)
Age, years 44 (19–95)
Male, n (%) 56 (90)
Time to pre-hospital sample, minutes post-injury 39 (13–59)
ISS 26 (9–57)
NISS 38 (9–75)
AIS
Head, n (%) 24 (48)
Face, n (%) 17 (34)
Chest, n (%) 29 (58)
Abdomen, n (%) 14 (28)
Spine, n (%) 19 (38)
Pelvis, n (%) 8 (16)
Limbs, n (%) 28 (56)
Other, n (%) 6 (12)
MECHANISM OF INJURY
Fall, n (%) 10 (16)
A/P, n (%) 13 (21)
Blunt, n (%) 2 (3)
RTC, n (%) 37 (60)
OUTCOMES
ICU-free days 22 (0–30)
Hospital-free days 13 (0–29)
Mortality, n (%) 8 (13)
Data are expressed as mean (range) unless indicated otherwise.
The number of data points for each clinical variable are: ISS and NISS, n= 48; AIS scores,
n = 50; ICU and hospital free days, n = 53.
ICU-free days and hospital-free days were calculated by 30 minus the number of days
the patient stayed in hospital).
A/P, Assault/penetrating; AIS, Abbreviated injury scale; ISS, Injury severity score; ICU,
Intensive care unit; NISS, New injury severity score; RTC, Road traffic collision.
observed (Figure 1A). In response to stimulation with PMA,
patient neutrophils released significantly less DNA at all three
sampling time-points when compared to HCs (Figure 1D).
Fluorescence microscopy confirmed the impairment in NET
generation (Figure 1E).
ROS Production in Response to PMA
Stimulation Is Reduced in the Acute
Post-injury Phase
ROS generation is a non-redundant event in NET formation
(17). Having observed trauma-induced alterations in both basal
and stimulated NET formation, we examined the effect of injury
on ROS production. In the absence of stimulation, patient
neutrophils isolated 48–72 h post-injury exhibited significantly
enhanced ROS production when compared to the response
of neutrophils from HCs (Figure 2A). No difference in basal
ROS generation was seen between HCs and patient neutrophils
acquired ≤1 h or 4–12 h post-injury (Figure 2A). In response
to PMA stimulation, there was a significant reduction in ROS
production, relative to HCs, for neutrophils isolated from
patients only at the 48–72 h post-injury time point (Figure 2B).
Frontiers in Immunology | www.frontiersin.org 5 April 2019 | Volume 10 | Article 685
Hazeldine et al. Neutrophil Dysfunction Post-trauma
FIGURE 1 | Effect of traumatic injury on PMA-induced NET formation. (A) Basal NET generation by resting neutrophils isolated from healthy controls (HC) and trauma
patients as assessed by DNA concentration in cell free supernatants following a 3 h in vitro culture. (B) HMGB-1 and (C) IL-33 concentrations in serum samples from
HC and trauma patients. IL-33 levels were undetectable (N.D) in serum samples from HC. (D,E) Following a 3 h in vitro stimulation with PMA, NET production by
neutrophils from HC and trauma patients was compared by measuring DNA concentration in cell free supernatants (D) and fluorescence microscopy (E). For
supernatant analysis, number of samples are shown below each time-point. For microscope images, HC (n = 12), ≤1 h (n = 6), 4–12 h (n = 6), and 48–72 h (n = 8).
*p < 0.01, **p < 0.001, ***p < 0.0001 vs. HC.
Traumatic Injury Results in an Immediate
and Sustained Elevation in the Frequency
and Absolute Number of Circulating IGs
Compared to their mature counterparts, immature neutrophils
exhibit impaired ex vivo NET production and reduced ROS
production upon stimulation with inflammatory agonists
(1, 27). Relative to the values recorded for HCs, trauma
patients presented, at all sampling time points, with a
significantly elevated frequency (Figure 2C) and absolute
number (Figure 2D) of circulating IGs.
Traumatic Injury Is Associated With
Impaired MAPK Signaling
MAPK signaling is a prerequisite for PMA-induced NET
production (20). Due to the significant lymphocytosis that occurs
within minutes of traumatic injury (3), and the small blood
volume collected from patients at the scene of injury, we were
unable to isolate a sufficient number of neutrophils from pre-
hospital blood samples to examineMAPK signaling. However, we
found neutrophils isolated from patients 4–12 and 48–72 h post-
injury exhibited significantly increased phosphorylation of P38
MAPK (Figure 3A) but not ERK1/2 (Figure 4A) in the absence
of exogenous stimulation.
In response to treatment with PMA, neutrophils obtained
fromHCs exhibited a significant increase in P38 phosphorylation
(Figures 3B–D). In contrast, no significant PMA-induced
increase in P38 phosphorylation was observed for neutrophils
isolated from trauma patients 4–12 or 48–72 hours post-injury
(Figures 3B–D). Compared to untreated cells, neutrophils
isolated from HCs and trauma patients at the 4–12 and
48–72 h post-injury time points displayed a significant
increase in ERK1/2 phosphorylation following 5, 10, and
15min of PMA stimulation (Figures 4B–D). However, across
these three stimulation time points, the degree of ERK1/2
phosphorylation was significantly greater in neutrophils isolated
from HCs (Figures 4B–D).
Altered Neutrophil Glucose Uptake and
Metabolism Post-trauma
Confirming the results of a recent study that demonstrated
a necessity for exogenous glucose in PMA-induced NET
production (21), we found neutrophils cultured in glucose free
media released significantly less DNA upon PMA stimulation
than neutrophils stimulated in glucose containing media
(Supplementary Figure 2). Based on our observation of a
trauma-induced impairment in ex vivoNET generation following
PMA treatment, we investigated the effect of injury on neutrophil
glucose uptake. Using the fluorescent glucose analog 2-NBDG,
enhanced basal glucose uptake was recorded for neutrophils
isolated from trauma patients within 1 h of injury (Figure 5A),
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FIGURE 2 | Neutrophil ROS production and immature granulocyte count post-injury. Comparison of basal (A) and PMA-induced (B) ROS production by neutrophils
isolated from healthy controls (HC) and trauma patients. Data are presented as area under the curve (AUC) (A) or fold increase above vehicle treated controls (B).
(C,D) Frequency (C) and absolute number (D) of immature granulocytes (IG) in peripheral blood samples from healthy controls (HC) and trauma patients. Number of
samples analyzed are shown below each time-point. *p < 0.01, **p < 0.001, ***p < 0.0001 vs. HC.
but in response to PMA stimulation, a significant trauma-
induced impairment in neutrophil glucose uptake was seen at all
sampling time points (Figure 5B).
We next examined whether injury impacted upon glucose
metabolism, a non-redundant step in NET formation triggered
by PMA stimulation (21). Using lactate production as
a marker of neutrophil glycolytic activity, we measured
lactate concentrations in supernatants collected from resting
and PMA-stimulated neutrophils following a 3 h in vitro
culture. Compared to HCs, neutrophils isolated from trauma
patients at the 48–72 h post-injury time-point exhibited
enhanced basal (Figure 5C) but impaired PMA-induced
lactate production (Figure 5D). The increase in basal lactate
generation was accompanied by a significant up-regulation in the
expression of the glycolytic enzymes pyruvate kinase and lactate
dehydrogenase A (Figures 5E,F).
Neutrophils Pre-treated With mtDAMPs
Exhibit Impaired NET Production but
Enhanced ROS Generation Upon
Secondary Stimulation
Compared to the levels measured in samples from HCs,
serum concentrations of the mitochondrial-derived protein
ND6 were significantly increased in patients at all post-
injury time points, confirming the release of mtDAMPs after
trauma (Figure 6A). Demonstrating the immune stimulatory
properties of mtDAMPs, we measured significantly reduced
CD62L, CXCR1, and CXCR2 expression as well as increased
CD11b density on the surface of mtDAMP treated neutrophils
(Supplementary Table 1). These changes in neutrophil surface
phenotype were accompanied by activation of ERK 1/2 MAPK
signaling (Supplementary Figure 3A). The emerging concept
of mtDAMP-induced tolerance of neutrophil function is based
in part on experimental data that has shown prior activation
of neutrophils with bacterial-derived N-formylated peptides
results in impaired migration upon secondary stimulation (10).
Confirming these findings, we found that neutrophils pre-treated
with 40 or 100µg/ml preparations of whole mtDAMPs exhibited
significantly reduced transmigration toward the chemokine
LTB4 (Supplementary Figure 3B). In contrast, no impairment
in migration was witnessed for neutrophils pre-treated with
100µg/ml of purified mtDNA (Supplementary Figure 3C).
To determine whether prior mtDAMP treatment influenced
PMA-induced NET production, fluorometric analysis was
performed on cell-free supernatants collected from cultures of
PMA stimulated neutrophils that had been pre-treated with
mtDAMPs or vehicle control. Analysis revealed neutrophils pre-
exposed to 40 or 100µg/ml mtDAMPs released significantly less
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FIGURE 3 | Traumatic injury results in impaired PMA-induced activation of p38 MAPK. Phosphorylation status of P38 in resting and PMA-stimulated neutrophils
isolated from healthy controls (HC) and trauma patients 4–12 and 48–72 h post-injury. Data are presented as representative Western blots (B) and densitometry
analysis of p38 phosphorylation in resting (A) or PMA-stimulated neutrophils at the 4–12 h (C) and 48–72 h (D) post-injury time points. HC (n = 7), 4–12 h (n = 9), and
48–72 h (n = 4). For (A) *p < 0.01, **p < 0.001 vs. HC. For (C) and (D) **p < 0.001 vs. Time 0, #p < 0.01, ###p < 0.0001 vs. HC sample at matched time point.
DNA following a 3 h stimulation with PMA than vehicle-
treated controls (Figure 6B). Fluorescence microscopy
confirmed this mtDAMP-induced inhibition of PMA-
induced NET generation (Figure 6C). Interestingly, focusing
upon neutrophils pre-treated with 100µg/ml mtDAMPs,
images revealed that despite a significant reduction in
NET formation, the cells had lost their multi-lobed nuclear
morphology following stimulation with PMA, presenting
with decondensed nuclear material (Figure 6C). In contrast
to whole mtDAMP preparations, neutrophils pre-treated
with 40µg/ml of purified mtDNA prior to PMA stimulation
showed no impairment in NET production (data not shown).
Interestingly, ROS production, which is a prerequisite for
NET formation, was significantly higher upon secondary
PMA stimulation for neutrophils pre-treated with 100µg/ml
mtDAMPs (Figure 6D).
AMPK Is Activated by mtDAMP Treatment
and Inhibition of AMPK Partially
Ameliorates the mtDAMP-Induced
Reduction in NET Formation
In stimulated T cells, elevated intracellular calcium levels
activate AMPK, a recently described negative regulator of
PMA-induced NET formation (28, 29). As raised intracellular
calcium levels are a feature of mtDAMP treated neutrophils
(23), we determined the activation status of AMPK in
neutrophils following mtDAMP stimulation. To do this,
cell lysates, prepared from neutrophils stimulated for 2, 5,
10, and 15min with 100µg/ml mtDAMPs, were probed
with a phospho-specific antibody directed against Thr172,
a residue within the activation loop of AMPK. As shown in
Figure 7A, mtDAMP treatment resulted in an immediate
and persistent phosphorylation of residue Thr172. Treating
neutrophils with the FPR-1 antagonist CsH prior to mtDAMP
stimulation resulted in a significant reduction in AMPK
phosphorylation, suggesting that N-formyl peptides drive
mtDAMP-induced activation of AMPK (Figure 7B). In
antigen challenged T cells, phosphorylation of AMPK requires
the activation of calcium-calmodulin-dependent protein
kinase kinases (CaMKKs), a class of serine/threonine protein
kinases activated by increases in intracellular calcium (28).
To investigate whether CaMKKs were involved in mtDAMP-
induced phosphorylation of AMPK in neutrophils, we treated
neutrophils with the CaMKK selective inhibitor STO-609
prior to mtDAMP stimulation. Compared to vehicle control,
a significant impairment in mtDAMP-induced activation
of AMPK was detected in neutrophils pre-treated with
STO-609 (Figure 7C).
AMPK has recently been shown to be a negative
regulator of PMA-induced NET formation (29, 30).
To investigate whether AMPK signaling was involved
in mtDAMP-mediated suppression of NET formation,
we treated neutrophils with compound C, an
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FIGURE 4 | Traumatic injury results in impaired PMA-induced activation of ERK MAPK. Phosphorylation status of ERK 1/2 in resting and PMA-stimulated neutrophils
isolated from healthy controls (HC) and trauma patients 4–12 and 48–72 h post-injury. Data are presented as representative Western blots (B) and densitometry
analysis of ERK phosphorylation in resting (A) or PMA-stimulated neutrophils at the 4–12 h (C) and 48–72 h (D) post-injury time points. HC (n = 4), 4–12 h (n = 8), and
48–72 h (n = 6). For (C) and (D) *p < 0.01, **p < 0.001, ***p < 0.0001 vs. Time 0, ##p < 0.001, ###p < 0.0001 vs. HC sample at matched time point.
inhibitor of AMPK, prior to mtDAMP exposure.
Compared to vehicle control, significantly greater
NET production in response to PMA stimulation
was recorded for neutrophils pre-treated with
compound C (Figure 7D).
MtDAMP Pre-treatment Results in
Impaired Lactate Generation by
Neutrophils Upon Secondary Stimulation
With PMA
Confirming results of previous studies that had shown AMPK to
be a negative regulator of aerobic glycolysis (31), we measured
significantly lower concentrations of lactate in supernatants
collected from PMA stimulated neutrophils that had been pre-
treated with the AMP mimetic AICAR when compared to
vehicle control (Figure 8A). Given that aerobic glycolysis is
a key metabolic event in PMA-induced NET formation (21)
and our observation of reduced NET generation following
PMA stimulation for neutrophils pre-treated with mtDAMPs
(Figures 6B,C), we investigated whether AMPK activation
triggered by mtDAMP exposure was associated with an
impairment in neutrophil glycolysis. Following 1, 2, or 3 h
stimulation with PMA, significantly lower lactate concentrations
were measured in supernatants collected from neutrophils pre-
treated with 100µg/ml mtDAMPs (Figure 8B).
DISCUSSION
Here, via the analysis of blood samples acquired from trauma
patients within 1 h of injury, we have shown for the first time that
major trauma results in an immediate impairment in neutrophil
anti-microbial defenses, specifically the formation of NETs. This
defect persisted into the acute post-injury phase (4–72 h) and was
accompanied by impaired ROS production, MAPK activation
and a reduction in both glucose uptake and breakdown.
Furthermore, we showed that the trauma-induced reduction
in NET formation could be replicated in vitro by treating
neutrophils isolated from healthy donors with mtDAMPs prior
to secondary stimulation. Thus, our data provides support for
the emerging concept of mtDAMP-induced tolerance, where
the post-injury release of mtDAMPs into the circulation has
been proposed to contribute to the neutrophil dysfunction that
develops in the aftermath of traumatic injury (10, 22).
In the absence of secondary stimulation, neutrophils obtained
from patients within minutes, but not hours, of injury
released significantly more DNA into culture supernatants than
neutrophils isolated from healthy controls. This immediate
trauma-induced increase in basal NET generation is in agreement
with the findings of our previous trauma-based study, where
in pre-hospital plasma samples, we reported the presence of
citrullinated histone H3, a protein that decorates the nuclear
DNA backbone of NETs (3, 32). Thus, taken together, our
results suggest that neutrophils are immediately exposed to
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FIGURE 5 | Effect of traumatic injury on neutrophil glucose uptake and metabolism. Glucose uptake by basal (A) or PMA-stimulated (B) neutrophils isolated from
healthy controls (HC) and trauma patients. MFI, Mean fluorescence intensity. (C,D) Comparison of lactate concentration in cell-free supernatants collected from resting
(C) or PMA stimulated (D) neutrophils isolated from HC and trauma patients following a 3 h in vitro culture. Number of samples analyzed are indicated below each
time-point. *p < 0.01, **p < 0.001, ***p < 0.0001 vs. HC. (E,F) Expression of the glycolytic enzymes pyruvate kinase (PKM2) and lactate dehydrogenase A (LDHA) in
resting neutrophils isolated from HC (n = 5) and trauma patients 48–72 h post-injury (n = 14). Data are presented as representative Western blots (E) and
densitometry analysis of collated data for LDHA (F, top panel) and PKM2 (F, bottom panel). *p < 0.01 vs. HC.
NET-inducing stimuli post-injury. Supporting this proposal,
data presented here and in our previous manuscript have
shown serum concentrations of known NET inducers, which
include TNF-α, IL-8, IL-33, and HMGB-1 are all significantly
elevated within minutes of injury (3, 15, 32–34). Of these
agonists, the immediate release of HMGB-1 may be particularly
pertinent given that within 60min of in vitro co-culture,
neutrophils stimulated with this nuclear-derived DAMP have
been shown to generate NETs (35). Moreover, as HMGB-1
induced NET formation is independent of ROS generation by
NADPH oxidase (15), immediate exposure to this DAMP could
explain our observation of enhanced ex vivo NET formation
by neutrophils isolated from pre-hospital blood samples that
exhibited no difference in basal ROS production when compared
to neutrophils from HCs. In terms of stimulus-induced NET
formation, this is the first study to show quantitatively that
trauma results in reduced NET generation to PMA stimulation.
We confirmed this impairment, which was evident at all three
sampling time points, by fluorescent microscopy, with our
images akin to those presented in a previous study that reported
a qualitative post-injury reduction in PMA-induced NET
production in a much smaller cohort of trauma patients (10).
The processes that mediate PMA-induced NET generation
are well-defined, with prominent roles assigned to ROS
generation, MAPK activation, glucose uptake and glycolysis
(17, 19–21). Across our sampling time points, we observed
defects in each of these processes, suggesting that multiple
impairments rather than a single aberration underlie the
post-injury reduction in NET formation. Whilst our data
demonstrating a trauma-induced impairment in neutrophil ROS
production has been described previously (1, 3), we are the
first to report a post-trauma reduction in MAPK activation,
glucose uptake, and metabolism by neutrophils in response
to ex vivo stimulation. Aside from NET production, other
anti-microbial mechanisms of neutrophils utilize glucose. For
instance, chemotaxis requires the uptake of exogenous glucose
(36), whilst breakdown of endogenous glucose is important for
stimulus-induced ROS production and phagocytosis (21, 36).
Interestingly, as reported here for NET generation, these three
defense strategies have all been shown in ex vivo assays to
be significantly impaired following trauma (1, 9–11). Thus,
the injury-induced reduction we have demonstrated in glucose
uptake and metabolism may be a mechanism underlying many
facets of post-trauma neutrophil dysfunction. Aside from the
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FIGURE 6 | Effect of mtDAMP pre-treatment on neutrophil NET generation. (A) Serum concentrations of the mitochondrial-derived N-formylated peptide ND6 in
peripheral blood samples acquired from healthy controls (HC) and trauma patients. Number of samples are indicated below each time-point. ***p < 0.0001 vs. HC.
(B) NET production by PMA stimulated neutrophils pre-treated with 40 or 100µg/ml mtDAMPs was assessed by measuring DNA content of cell-free supernatants (n
= 5). *p < 0.01 vs. Vehicle. (C) MtDAMP-induced inhibition of NET generation was confirmed by fluorescence microscopy (n = 5; top panel x20 magnification; bottom
panel x40 magnification). (D) ROS generation by neutrophils pre-treated with 100µg/ml mtDAMPs or vehicle control was measured in response to stimulation with
25 nM PMA using luminol-based chemiluminescence (n = 10). Data are presented as area under the curve (AUC) and are mean ± SEM. ***p < 0.0001 vs. PMA.
changes we found in neutrophil signaling and metabolism,
trauma patients presented at all three time points with elevated
circulating levels of IGs. Shown in vitro to exhibit impaired NET
production upon secondary stimulation (27), the immediate and
persistent presence of immature cells offers another potential
mechanistic explanation for the trauma-induced reduction in
NET formation.
Suggesting that traumatic injury modulates cell metabolism,
we demonstrated a post-trauma elevation in lactate production
by resting neutrophils, an observation that is in agreement with
the findings of a previous study. In a cohort of polytrauma
patients, Oehler et al. reported a higher glycolytic activity,
relative to HCs, for neutrophils isolated from subjects between
48 and 120 h post-injury, an enhancement they attributed to
increased expression and activity of pyruvate kinase, a glycolytic
enzyme that catalyzes the conversion of phosphoenolpyruvate
to pyruvate (37). Here, we confirmed that traumatic injury
induces increased expression of pyruvate kinase and showed
that this is accompanied by increased expression of lactate
dehydrogenase A. Whilst up-regulation of lactate dehydrogenase
A, which converts pyruvate to lactate, has been described in
transcriptomic analysis of whole blood leukocytes isolated from
critically-ill patients (38), this is the first study to demonstrate
increased protein expression of lactate dehydrogenase in
neutrophils post-injury.
Accompanying the impairment we observed in ex vivo
NET formation was a significant trauma-induced elevation
in the circulating levels of the mitochondrial-derived N-
formylated peptide ND6. In a recent study, suppressed
chemotactic responses toward CXCL1 and LTB4 were
reported for neutrophils pre-treated with synthetic ND6
(22), a finding that mirrored results of previous studies where
prior exposure to bacterial-derived N-formylated peptides or
ND6 respectively was shown to reduce neutrophil migration and
ROS production upon secondary stimulation (10, 26). Adding
to this growing body of literature that suggests a tolerising
effect for mitochondrial-derived peptides on neutrophil
function, we demonstrated that neutrophils pre-treated with
whole mtDAMP preparations, but not purified mtDNA,
exhibited significantly reduced NET production following
PMA stimulation.
A striking observation of our NET based assays was that
despite an absence of NET production, mtDAMP pre-treated
neutrophils lost their distinctivemulti-lobed nuclearmorphology
upon PMA challenge. Interestingly, chromatin decondensation
in the absence of DNA release was recently reported for
PMA stimulated neutrophils pre-treated with the glycolysis
inhibitor 2-deoxy-glucose (21). Using lactate as a readout of
glycolytic activity, we measured significantly reduced lactate
concentrations in the supernatants of mtDAMP pre-treated
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FIGURE 7 | Treatment of neutrophils with mtDAMPs results in phosphorylation of AMPK. (A) Whole cell lysates prepared from purified neutrophils stimulated for
2–15min with 100µg/ml mtDAMPs were screened for phosphorylated AMPK. Western blot in top panel is representative of 4 independent experiments. For
densitometry analysis ***p < 0.0001 vs. 0min. (B) AMPK phosphorylation in neutrophils treated for 1 h with the FPR-1 antagonist Cyclosporin H (CsH) or (C) or the
CaMKK inhibitor STO-609 prior to a 5min stimulation with 100µg/ml mtDAMPs. Blots are representative of 5 (B) and 10 (C) independent experiments, with
densitometric data depicted in the accompanying histogram. **p < 0.001, ***p < 0.0001 vs. vehicle. (D) Comparison of PMA-induced NET formation by mtDAMP
stimulated neutrophils pre-treated with the AMPK inhibitor compound C or vehicle control (n = 10). **p < 0.01 vs. PMA treated.
neutrophils stimulated with PMA, demonstrating that exposure
to mtDAMPs influences the metabolism of immune cells.
We found that exposing neutrophils to mtDAMPs resulted
in activation of the serine/threonine protein kinase AMPK. In
T cells, increases in intracellular calcium levels promote AMPK
phosphorylation through activation of CaMKKs (28). Our data
demonstrating a significant reduction in mtDAMP-induced
phosphorylation of AMPK in neutrophils pre-treated with the
selective CAMMK inhibitor STO-506 indicates this signaling
pathway is also activated in stimulated neutrophils. As the only
component of mtDAMPs that promotes calcium mobilization
in neutrophils (23), signals derived from N-formyl peptides are
likely to have driven the mtDAMP-induced phosphorylation of
AMPK. Supporting this idea, we observed significantly reduced
mtDAMP-induced AMPK phosphorylation in neutrophils pre-
treated with CsH, an FPR-1 antagonist that prevents calcium
mobilization upon mtDAMP stimulation (23).
Demonstrating that AMPK is a negative regulator of NET
formation, significantly enhanced and impaired NET formation
has been reported for PMA stimulated neutrophils pre-treated
with AMPK inhibitors and activators respectively (29, 30).
Supporting these data, we showed significantly greater PMA-
induced NET production by neutrophils treated with the
AMPK inhibitor compound C prior to mtDAMP exposure.
How activation of AMPK inhibits NET formation is currently
unknown. Based on published literature, we propose two
mechanisms, both of which revolve around the ability of
AMPK to inhibit the serine/threonine protein kinase mammalian
target of rapamycin (mTOR) (31, 39). Firstly, inhibition of
mTOR has been shown to significantly reduce Glut1 transporter
activity (40). Given the importance of extracellular-derived
glucose in NET formation (21), reduced glucose uptake,
secondary to impaired mTOR and Glut1 activity, could
contribute to the reduction in NET production and lactate
generation that we observed for neutrophils pre-treated with
mtDAMPs. Furthermore, this mechanism could contribute to
the mtDAMP-induced impairment we reported in neutrophil
transmigration since chemotaxis also utilizes extracellular
sources of glucose (36). Alongside Glut1, mTOR signaling
has been implicated in regulating the expression/activity of
hypoxia-inducible factor-1α (HIF-1α) (31). A transcription
factor involved in promoting aerobic glycolysis, activation of
HIF-1α precedes both NET formation (41) and myeloid cell
migration (42). Thus, reduced activity/expression of HIF-1α,
secondary to AMPK-mediated inhibition of mTOR, could be
an additional/alternative explanation for the mtDAMP-induced
reduction in lactate generation, NET generation and neutrophil
chemotaxis. Importantly, both these proposedmechanisms could
occur in neutrophils without affecting their capacity for ROS
production, which we foundwas significantly increased following
mtDAMP treatment. Indeed, as the energy required for ROS
generation is derived from endogenous sources of glucose (21),
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FIGURE 8 | MtDAMP pre-treatment results in impaired neutrophil glycolysis.
(A) Neutrophils pre-treated for 1 h with 1mM AICAR or vehicle control were
stimulated for 3 h with 25 nM PMA, after which lactate concentrations were
measured in cell-free supernatants. Data are mean ± SEM of 12 independent
experiments. ***p < 0.0001. (B) Comparison of lactate concentrations in
supernatants collected from neutrophils pre-treated with 100µg/ml mtDAMPs
or vehicle-control and subsequently stimulated with 25 nM PMA for 1, 2, and
3 h. Data are mean ± SEM of 10 independent experiments. **p < 0.001, ***p
< 0.0001 vs. vehicle.
this anti-microbial function could occur in the background
of an AMPK driven reduction in extracellular glucose uptake.
Our finding of increased ROS production to PMA stimulation
for neutrophils pre-treated with mtDAMPs contradicts the
post-injury impairment we reported in ROS generation for
trauma patients that presented with significantly elevated serum
concentrations of mtDAMPs. We believe this discrepancy may
be attributable to trauma-induced changes in the composition
of the circulating neutrophil pool. For example, traumatic injury
results in the emergence into circulation of IGs and CD16BRIGHT
CD62LDIM neutrophils, both of which exhibit impaired stimulus-
induced ROS generation (43, 44). In contrast, healthy subjects,
who served as the cohort for our mtDAMP pre-treatment
experiments, possess a homogenous pool of fully-functional
mature neutrophils that would exhibit a greater capacity to
respond to stimulation.
Although we have shown that neutrophils pre-treated with
compound C exhibit increased NET generation upon PMA
stimulation, inhibition of AMPK only partially ameliorated
the reduction in NET formation that occurred with mtDAMP
treatment. Other factors aside from AMPK activation must
therefore be involved in mediating the mtDAMP-induced
suppression of NET production. Recently, through a proposed
mechanism of action that involved the prevention of membrane
rupture, lactoferrin, an iron-binding glycoprotein stored within
the secondary granules of neutrophils, was found to suppress
NET release triggered by PMA stimulation (45). Indicative of
a defect in the latter stages of NET production, we showed
chromatin decondensation in the absence of DNA release
was a feature of mtDAMP-treated neutrophils. Thus, based
on this observation and the fact that exposure to mtDAMPs
promotes neutrophil degranulation (23, 24, 46), we suggest that
a mtDAMP-induced release of lactoferrin could represent an
additional mechanistic explanation for the impairment in NET
formation that occurs following mtDAMP exposure.
This study has some limitations. Conducted at a single major
trauma center, the results of our prospective observational study
are based on the analysis of a small number of patient samples,
meaning our findings require validation in larger independent
cohorts. This point is particularly pertinent to our analysis of
pre-hospital blood samples, where inter-individual variability
in immune cell number and volume of blood collected at the
scene of injury meant we were unable to perform all assays on
each patient at this time point. As a heterogeneous collection of
proteins, lipids and DNA, no study to date has quantified the
exact concentration of mtDAMPs released into the circulation
post-injury. Thus, our in vitro treatment of neutrophils with 40
or 100µg/ml mtDAMPs may not be physiologically relevant.
However, these doses match those used in previous in vitro based
studies that have examined the effect of mtDAMP exposure on
neutrophil anti-microbial function (23, 24, 46). Similarly, our
decision to use the phorbol ester PMA as an agonist may be
considered a study limitation. However, as a potent stimulus, it
allowed us to study maximal neutrophil responses. Moreover, as
the agonist of choice for all previous trauma-based studies that
had examined stimulus-induced NET production post-injury (1,
10, 13), our use of PMA enabled us to compare our observations
to those in the published literature.
In summary, this is the first study to describe a quantitative
post-trauma reduction in NET formation as an immediate
on-scene phenomenon, which is accompanied by aberrant
intracellular signaling and cell metabolism. In addition, we
have shown that the post-injury reduction in NET generation
can be recreated in vitro by treating neutrophils isolated from
healthy subjects with mtDAMPs prior to PMA stimulation.
Thus, our data support the suggestion that the release of
mtDAMPs from damaged tissue is a contributory factor in
the reduction in neutrophil function that occurs post-injury
(1, 3, 9–11).
DATA AVAILABILITY
The datasets generated for this study are available on request to
the corresponding author.
Frontiers in Immunology | www.frontiersin.org 13 April 2019 | Volume 10 | Article 685
Hazeldine et al. Neutrophil Dysfunction Post-trauma
AUTHOR CONTRIBUTIONS
JH designed the study, performed experimental work, analyzed
data, and wrote the manuscript. RD performed experimental
work and analyzed data. PH critically appraised the manuscript
and JL conceptualized the study and contributed to writing
the manuscript.
FUNDING
For funding this research, the authors acknowledge the National
Institute for Health Research Surgical Reconstruction and
Microbiology Research Center (NIHR SRMRC; http://www.
nihr.ac.uk). The authors would also like to acknowledge
the Queen Elizabeth Hospital Birmingham Charity for
funding the purchase of the Sysmex XN-1000 hematology
analyser (https://www.qehb.org).
ACKNOWLEDGMENTS
The views expressed are those of the author(s) and not necessarily
those of the NHS, the NIHR or the Department of Health.
The authors thank all the research, nursing, and administrative
staff at the NIHR-SRMRC for their assistance in data collection
and management. We also thank the emergency healthcare
professionals in the West Midlands Ambulance Service NHS
Foundation Trust, the Midlands Air Ambulance Charity and
the University Hospitals BirminghamNHS Foundation Trust for
their participation in the identification, enrolment and follow up
of patients in this study.
SUPPLEMENTARY MATERIAL
The Supplementary Material for this article can be found
online at: https://www.frontiersin.org/articles/10.3389/fimmu.
2019.00685/full#supplementary-material
REFERENCES
1. Hampson P, Dinsdale RJ, Wearn CM, Bamford AL, Bishop JRB, Hazeldine
J, et al. Neutrophil dysfunction, immature granulocytes, and cell-
free DNA are early biomarkers of sepsis in burn-injured patients: a
prospective observational cohort study. Ann Surg. (2017) 265:1241–9.
doi: 10.1097/SLA.0000000000001807
2. Hazeldine J, Hampson P, Lord JM. The impact of trauma on neutrophil
function. Injury. (2014) 45:1824–33. doi: 10.1016/j.injury.2014.06.021
3. Hazeldine J, Naumann DN, Toman E, Davies D, Bishop JRB, Su Z,
et al. Prehospital immune responses and development of multiple organ
dysfunction syndrome following traumatic injury: a prospective cohort study.
PLoS Med. (2017) 14:e1002338. doi: 10.1371/journal.pmed.1002338
4. Leliefeld PH, Wessels CM, Leenen LP, Koenderman L, Pillay J. The role of
neutrophils in immune dysfunction during severe inflammation. Crit Care.
(2016) 20:73. doi: 10.1186/s13054-016-1250-4
5. Pillay J, Kamp VM, van HE, Visser T, Tak T, Lammers JW, et al. A subset
of neutrophils in human systemic inflammation inhibits T cell responses
through Mac-1. J Clin Invest. (2012) 122:327–36. doi: 10.1172/JCI57990
6. Johansson J, Sjogren F, Bodelsson M, Sjoberg F. Dynamics of leukocyte
receptors after severe burns: an exploratory study. Burns. (2011) 37:227–33.
doi: 10.1016/j.burns.2010.08.015
7. Visser T, Hietbrink F, Groeneveld KM, Koenderman L, Leenen LP. Isolated
blunt chest injury leads to transient activation of circulating neutrophils. Eur
J Trauma Emerg Surg. (2011) 37:177–84. doi: 10.1007/s00068-010-0041-x
8. Visser T, Pillay J, Pickkers P, Leenen LP, Koenderman L. Homology in systemic
neutrophil response induced by human experimental endotoxemia and by
trauma. Shock. (2012) 37:145–51. doi: 10.1097/SHK.0b013e31823f14a4
9. Liao Y, Liu P, Guo F, Zhang ZY, Zhang Z. Oxidative burst of circulating
neutrophils following traumatic brain injury in human. PLoS ONE. (2013)
8:e68963. doi: 10.1371/journal.pone.0068963
10. Li H, Itagaki K, Sandler N, Gallo D, Galenkamp A, Kaczmarek E, et al.
Mitochondrial damage-associated molecular patterns from fractures suppress
pulmonary immune responses via formyl peptide receptors 1 and 2. J
Trauma Acute Care Surg. (2015) 78:272–9. doi: 10.1097/TA.00000000000
00509
11. Tarlowe MH, Kannan KB, Itagaki K, Adams JM, Livingston DH, Hauser
CJ. Inflammatory chemoreceptor cross-talk suppresses leukotriene B4
receptor 1-mediated neutrophil calcium mobilization and chemotaxis
after trauma. J Immunol. (2003) 171:2066–73. doi: 10.4049/jimmunol.171.
4.2066
12. Brinkmann V, Zychlinsky A. Neutrophil extracellular traps: is immunity
the second function of chromatin? J Cell Biol. (2012) 198:773–83.
doi: 10.1083/jcb.201203170
13. Itagaki K, Kaczmarek E, Lee YT, Tang IT, Isal B, Adibnia Y, et al. Mitochondrial
DNA released by trauma induces neutrophil extracellular traps. PLoS ONE.
(2015) 10:e0120549. doi: 10.1371/journal.pone.0120549
14. Cohen MJ, Brohi K, Calfee CS, Rahn P, Chesebro BB, Christiaans SC, et al.
Early release of high mobility group box nuclear protein 1 after severe trauma
in humans: role of injury severity and tissue hypoperfusion. Crit Care. (2009)
13:R174. doi: 10.1186/cc8152
15. Tadie JM, Bae HB, Jiang S, Park DW, Bell CP, Yang H, et al. HMGB1 promotes
neutrophil extracellular trap formation through interactions with Toll-like
receptor 4. Am J Physiol Lung Cell Mol Physiol. (2013) 304:L342–L349.
doi: 10.1152/ajplung.00151.2012
16. Xu J, Guardado J, Hoffman R, Xu H, Namas R, Vodovotz Y, et al.
IL33-mediated ILC2 activation and neutrophil IL5 production in the
lung response after severe trauma: a reverse translation study from a
human cohort to a mouse trauma model. PLoS Med. (2017) 14:e1002365.
doi: 10.1371/journal.pmed.1002365
17. Fuchs TA, Abed U, Goosmann C, Hurwitz R, Schulze I, Wahn V, et al. Novel
cell death program leads to neutrophil extracellular traps. J Cell Biol. (2007)
176:231–41. doi: 10.1083/jcb.200606027
18. Kirchner T, Moller S, Klinger M, SolbachW, Laskay T, Behnen M. The impact
of various reactive oxygen species on the formation of neutrophil extracellular
traps.Mediators Inflamm. (2012) 2012:849136. doi: 10.1155/2012/849136
19. Hakkim A, Fuchs TA, Martinez NE, Hess S, Prinz H, Zychlinsky
A, et al. Activation of the Raf-MEK-ERK pathway is required for
neutrophil extracellular trap formation. Nat Chem Biol. (2011) 7:75–7.
doi: 10.1038/nchembio.496
20. Keshari RS, Verma A, Barthwal MK, Dikshit M. Reactive oxygen species-
induced activation of ERK and p38 MAPK mediates PMA-induced NETs
release from human neutrophils. J Cell Biochem. (2013) 114:532–40.
doi: 10.1002/jcb.24391
21. Rodriguez-Espinosa O, Rojas-Espinosa O, Moreno-Altamirano MM,
Lopez-Villegas EO, Sanchez-Garcia FJ. Metabolic requirements for
neutrophil extracellular traps formation. Immunology. (2015) 145:213–24.
doi: 10.1111/imm.12437
22. Kaczmarek E, Hauser CJ, KwonWY, Rica I, Chen L, Sandler N, et al. A subset
of five human mitochondrial formyl peptides mimics bacterial peptides and
functionally deactivates human neutrophils. J Trauma Acute Care Surg. (2018)
85:936–43. doi: 10.1097/TA.0000000000001971
Frontiers in Immunology | www.frontiersin.org 14 April 2019 | Volume 10 | Article 685
Hazeldine et al. Neutrophil Dysfunction Post-trauma
23. Zhang Q, Raoof M, Chen Y, Sumi Y, Sursal T, Junger W, et al. Circulating
mitochondrial DAMPs cause inflammatory responses to injury. Nature.
(2010) 464:104–7. doi: 10.1038/nature08780
24. Hazeldine J, Hampson P, Opoku FA, Foster M, Lord JM. N-Formyl
peptides drive mitochondrial damage associated molecular pattern
induced neutrophil activation through ERK1/2 and P38 MAP kinase
signaling pathways. Injury. (2015) 46:975–84. doi: 10.1016/j.injury.201
5.03.028
25. Fernandez-Ruiz I, Arnalich F, Cubillos-Zapata C, Hernandez-Jimenez
E, Moreno-Gonzalez R, Toledano V, et al. Mitochondrial DAMPs
induce endotoxin tolerance in human monocytes: an observation
in patients with myocardial infarction. PLoS ONE. (2014) 9:e95073.
doi: 10.1371/journal.pone.0095073
26. Gabl M, Sundqvist M, Holdfeldt A, Lind S, Martensson J, Christenson K, et al.
Mitocryptides from human mitochondrial DNA-encoded proteins activate
neutrophil formyl peptide receptors: receptor preference and signaling
properties. J Immunol. (2018) 200:3269–82. doi: 10.4049/jimmunol.17
01719
27. Martinelli S, Urosevic M, Daryadel A, Oberholzer PA, Baumann C, Fey MF,
et al. Induction of genes mediating interferon-dependent extracellular trap
formation during neutrophil differentiation. J Biol Chem. (2004) 279:44123–
32. doi: 10.1074/jbc.M405883200
28. Tamas P, Hawley SA, Clarke RG, Mustard KJ, Green K, Hardie DG, et al.
Regulation of the energy sensor AMP-activated protein kinase by antigen
receptor and Ca2+ in T lymphocytes. J Exp Med. (2006) 203:1665–70.
doi: 10.1084/jem.20052469
29. Wang H, Li T, Chen S, Gu Y, Ye S. Neutrophil extracellular trap mitochondrial
DNA and its autoantibody in systemic lupus erythematosus and a proof-
of-concept trial of metformin. Arthritis Rheumatol. (2015) 67:3190–200.
doi: 10.1002/art.39296
30. Jiang S, Park DW, Tadie JM, Gregoire M, Deshane J, Pittet JF, et al. Human
resistin promotes neutrophil proinflammatory activation and neutrophil
extracellular trap formation and increases severity of acute lung injury. J
Immunol. (2014) 192:4795–803. doi: 10.4049/jimmunol.1302764
31. Faubert B, Boily G, Izreig S, Griss T, Samborska B, Dong Z, et al. AMPK is a
negative regulator of theWarburg effect and suppresses tumor growth in vivo.
Cell Metab. (2013) 17:113–24. doi: 10.1016/j.cmet.2012.12.001
32. Liu CL, Tangsombatvisit S, Rosenberg JM, Mandelbaum G, Gillespie
EC, Gozani OP, et al. Specific post-translational histone modifications of
neutrophil extracellular traps as immunogens and potential targets of lupus
autoantibodies. Arthritis Res Ther. (2012) 14:R25. doi: 10.1186/ar3707
33. Keshari RS, Jyoti A, Dubey M, Kothari N, Kohli M, Bogra J, et al.
Cytokines induced neutrophil extracellular traps formation: implication
for the inflammatory disease condition. PLoS ONE. (2012) 7:e48111.
doi: 10.1371/journal.pone.0048111
34. Yazdani HO, Chen HW, Tohme S, Tai S, van der Windt DJ, Loughran
P, et al. IL-33 exacerbates liver sterile inflammation by amplifying
neutrophil extracellular trap formation. J.Hepatol. (2017) 68:130–139.
doi: 10.1016/j.jhep.2017.09.010
35. Huang H, Tohme S, Al-Khafaji AB, Tai S, Loughran P, Chen L, et al.
Damage-associated molecular pattern-activated neutrophil extracellular trap
exacerbates sterile inflammatory liver injury. Hepatology. (2015) 62:600–14.
doi: 10.1002/hep.27841
36. Weisdorf DJ, Craddock PR, Jacob HS. Glycogenolysis versus glucose
transport in human granulocytes: differential activation in phagocytosis and
chemotaxis. Blood. (1982) 60:888–93.
37. Oehler R, Weingartmann G, Manhart N, Salzer U, Meissner M, Schlegel
W, et al. Polytrauma induces increased expression of pyruvate kinase in
neutrophils. Blood. (2000) 95:1086–92.
38. Nalos M, Parnell G, Robergs R, Booth D, McLean AS, Tang BM.
Transcriptional reprogramming of metabolic pathways in critically ill
patients. Intensive CareMed Exp. (2016) 4:21. doi: 10.1186/s40635-016-0094-1
39. MacIver NJ, Blagih J, Saucillo DC, Tonelli L, Griss T, Rathmell JC, et al. The
liver kinase B1 is a central regulator of T cell development, activation, and
metabolism. J Immunol. (2011) 187:4187–98. doi: 10.4049/jimmunol.1100367
40. Wieman HL, Wofford JA, Rathmell JC. Cytokine stimulation promotes
glucose uptake via phosphatidylinositol-3 kinase/Akt regulation of
Glut1 activity and trafficking. Mol Biol Cell. (2007) 18:1437–46.
doi: 10.1091/mbc.e06-07-0593
41. McInturff AM, Cody MJ, Elliott EA, Glenn JW, Rowley JW, Rondina MT,
et al. Mammalian target of rapamycin regulates neutrophil extracellular trap
formation via induction of hypoxia-inducible factor 1 alpha. Blood. (2012)
120:3118–25. doi: 10.1182/blood-2012-01-405993
42. Cramer T, Yamanishi Y, Clausen BE, Forster I, Pawlinski R, Mackman N, et al.
HIF-1alpha is essential for myeloid cell-mediated inflammation. Cell. (2003)
112:645–57. doi: 10.1016/S0092-8674(03)00154-5
43. Drifte G, Dunn-Siegrist I, Tissieres P, Pugin J. Innate immune functions
of immature neutrophils in patients with severe sepsis and severe systemic
inflammatory response syndrome. Crit Care Med. (2013) 41:820–32.
doi: 10.1097/CCM.0b013e318274647d
44. Sauce D, Dong Y, Campillo-Gimenez L, Casulli S, Bayard C, Autran B, et al.
Reduced oxidative burst by primed neutrophils in the elderly individuals
is associated with increased levels of the CD16BRIGHT/CD62LDIM
immunosuppressive subset. J Gerontol A Biol Sci Med Sci. (2017) 72:163–72.
doi: 10.1093/gerona/glw062
45. Okubo K, Kamiya M, Urano Y, Nishi H, Herter JM, Mayadas T,
et al. Lactoferrin suppresses neutrophil extracellular traps release in
inflammation. EBioMedicine. (2016) 10:204–15. doi: 10.1016/j.ebiom.2016.
07.012
46. Hauser CJ, Sursal T, Rodriguez EK, Appleton PT, Zhang Q, Itagaki K.
Mitochondrial damage associated molecular patterns from femoral
reamings activate neutrophils through formyl peptide receptors
and P44/42 MAP kinase. J Orthop Trauma. (2010) 24:534–8.
doi: 10.1097/BOT.0b013e3181ec4991
Conflict of Interest Statement: The authors declare that the research was
conducted in the absence of any commercial or financial relationships that could
be construed as a potential conflict of interest.
Copyright © 2019 Hazeldine, Dinsdale, Harrison and Lord. This is an open-access
article distributed under the terms of the Creative Commons Attribution License (CC
BY). The use, distribution or reproduction in other forums is permitted, provided
the original author(s) and the copyright owner(s) are credited and that the original
publication in this journal is cited, in accordance with accepted academic practice.
No use, distribution or reproduction is permitted which does not comply with these
terms.
Frontiers in Immunology | www.frontiersin.org 15 April 2019 | Volume 10 | Article 685
